ZA935340B - Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity - Google Patents
Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activityInfo
- Publication number
- ZA935340B ZA935340B ZA935340A ZA935340A ZA935340B ZA 935340 B ZA935340 B ZA 935340B ZA 935340 A ZA935340 A ZA 935340A ZA 935340 A ZA935340 A ZA 935340A ZA 935340 B ZA935340 B ZA 935340B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkyl
- group
- compound
- hydrogen
- arylethanolamine
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 230000002058 anti-hyperglycaemic effect Effects 0.000 title 1
- 230000003579 anti-obesity Effects 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 150000002431 hydrogen Chemical class 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 150000002825 nitriles Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929215844A GB9215844D0 (en) | 1992-07-25 | 1992-07-25 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA935340B true ZA935340B (en) | 1994-05-16 |
Family
ID=10719297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA935340A ZA935340B (en) | 1992-07-25 | 1993-07-23 | Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5519006A (de) |
| EP (1) | EP0652884B1 (de) |
| JP (1) | JPH07509458A (de) |
| CN (1) | CN1101349A (de) |
| AT (1) | ATE153666T1 (de) |
| AU (1) | AU4715193A (de) |
| CA (1) | CA2140916A1 (de) |
| DE (1) | DE69311118T2 (de) |
| GB (1) | GB9215844D0 (de) |
| MX (1) | MX9304467A (de) |
| TW (1) | TW249804B (de) |
| WO (1) | WO1994002493A1 (de) |
| ZA (1) | ZA935340B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0711284A1 (de) * | 1993-07-31 | 1996-05-15 | Smithkline Beecham Plc | 2-benzoheterocyclyloxy oder thiopropanolamine derivate mit adreno rezeptor agonist wirkung |
| AU7692394A (en) * | 1993-09-09 | 1995-03-27 | Smithkline Beecham Plc | Phosphinic acid derivatives with anti-hyper glycemic and/or anti-obesity activity |
| US5561142A (en) * | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| US5541197A (en) * | 1994-04-26 | 1996-07-30 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| HUT76800A (en) * | 1994-07-29 | 1997-11-28 | Smithkline Beecham Plc | Aryloxy- and arylthiopropanolamine derivatives and pharmaceutical compositions thereof |
| US5726165A (en) * | 1994-07-29 | 1998-03-10 | Smithkline Beecham P.L.C. | Derivatives of 4-(2-aminoethyl)phenoxymethyl-phosphonic and -phosphinic acid and pharmaceutical and veterinary uses therefor |
| US5491134A (en) * | 1994-09-16 | 1996-02-13 | Bristol-Myers Squibb Company | Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives |
| ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
| EP0827746B1 (de) | 1996-09-05 | 2002-04-03 | Eli Lilly And Company | Carbazolanaloge als selektive beta3-adrenergische Agonisten |
| US5808080A (en) | 1996-09-05 | 1998-09-15 | Eli Lilly And Company | Selective β3 adrenergic agonists |
| CO5011072A1 (es) * | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
| GB0311406D0 (en) * | 2003-05-17 | 2003-06-25 | Queen Mary & Westfield College | Substituted phosphonate fluorescent sensors,and use thereof |
| TWI501850B (zh) * | 2013-04-24 | 2015-10-01 | Rexon Ind Corp Ltd | 磁磚切割機之刀具護蓋裝置 |
| CN103372020A (zh) * | 2013-07-04 | 2013-10-30 | 丁圣雨 | Chukrasone A在促胰岛素分泌药物中的应用 |
| EP3773433B1 (de) | 2018-03-28 | 2021-10-13 | Unilever IP Holdings B.V. | Aluminiumfreie schweisshemmende zusammensetzungen |
| CN117585653B (zh) * | 2023-11-13 | 2024-08-09 | 湖北三峡实验室 | 一种多次沉淀法制备低成本电池级磷酸铁的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0102213A1 (de) * | 1982-08-21 | 1984-03-07 | Beecham Group Plc | Ethanolaminderivate, sie enthaltende pharmazeutische Mittel sowie Verfahren zu ihrer Herstellung |
| GB8620951D0 (en) * | 1986-08-29 | 1986-10-08 | Beecham Group Plc | Compounds |
| US5061727A (en) * | 1990-05-04 | 1991-10-29 | American Cyanamid Company | Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles |
-
1992
- 1992-07-25 GB GB929215844A patent/GB9215844D0/en active Pending
-
1993
- 1993-07-22 WO PCT/GB1993/001554 patent/WO1994002493A1/en active IP Right Grant
- 1993-07-22 AU AU47151/93A patent/AU4715193A/en not_active Abandoned
- 1993-07-22 JP JP6504304A patent/JPH07509458A/ja active Pending
- 1993-07-22 DE DE69311118T patent/DE69311118T2/de not_active Expired - Fee Related
- 1993-07-22 AT AT93917898T patent/ATE153666T1/de not_active IP Right Cessation
- 1993-07-22 EP EP93917898A patent/EP0652884B1/de not_active Expired - Lifetime
- 1993-07-22 CA CA002140916A patent/CA2140916A1/en not_active Abandoned
- 1993-07-23 MX MX9304467A patent/MX9304467A/es unknown
- 1993-07-23 ZA ZA935340A patent/ZA935340B/xx unknown
- 1993-07-24 CN CN93116857A patent/CN1101349A/zh active Pending
- 1993-07-27 TW TW082105988A patent/TW249804B/zh active
-
1995
- 1995-03-30 US US08/374,745 patent/US5519006A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0652884A1 (de) | 1995-05-17 |
| EP0652884B1 (de) | 1997-05-28 |
| TW249804B (de) | 1995-06-21 |
| ATE153666T1 (de) | 1997-06-15 |
| AU4715193A (en) | 1994-02-14 |
| US5519006A (en) | 1996-05-21 |
| GB9215844D0 (en) | 1992-09-09 |
| WO1994002493A1 (en) | 1994-02-03 |
| DE69311118D1 (de) | 1997-07-03 |
| JPH07509458A (ja) | 1995-10-19 |
| DE69311118T2 (de) | 1997-09-25 |
| CN1101349A (zh) | 1995-04-12 |
| MX9304467A (es) | 1994-04-29 |
| CA2140916A1 (en) | 1994-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA935340B (en) | Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity | |
| GB8919434D0 (en) | Novel compounds | |
| ATE33838T1 (de) | Thiazolidinderivate, ihre herstellung und diese enthaltende zusammensetzungen. | |
| MY102866A (en) | Amide derivatives. | |
| ES8706608A1 (es) | Un procedimiento para preparar derivados de arilciclobutilalquilamina | |
| IE56605B1 (en) | Phosphorous containing amide compounds,pharmaceutical compositions containing them,and processes for their preparation | |
| GB9408185D0 (en) | New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | |
| ES8306142A1 (es) | "procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil)-bencimidazolonas sustituidas". | |
| ES8400393A1 (es) | Un procedimiento para la preparacion de nuevos derivados de ariletanolamina. | |
| ES468173A1 (es) | Un procedimiento para la preparacion de derivados de morfina | |
| ES482472A1 (es) | Procedimiento para la preparacion de isoquinoleinas. | |
| SE8403268L (sv) | 1,4-dihydropyridinderivat, deras framstellning och farmaceutiska beredningar innehallande dessa | |
| ES8207538A1 (es) | Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilicos 6-, 1- y 2-sustituidos. | |
| ES8402839A1 (es) | Procedimiento para la obtencion de nuevos poliazaheterociclicos policiclicos. | |
| ATE18211T1 (de) | Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen. | |
| ES2018403A6 (es) | Procedimiento para preparar nuevas 2-carbonil sustituido-n, n' -di(trimetoxibenzoil) -piperazinas. | |
| IE41219L (en) | Aralkyl esters of aminoalkanoic acids | |
| JPS55111469A (en) | Novel geldanamycin derivative, its preparation, and antitumor drug comprising it as active ingredient | |
| GR3001468T3 (en) | 5-aminoalkyl-beta-carboline derivatives, their preparation and their use as medicaments | |
| ES8405020A1 (es) | Un procedimiento para la preparacion de derivados de fosfolipidos. | |
| ES8703441A1 (es) | Un procedimiento para la preparacion de agentes anti-hiperglicemicos de lactona. | |
| WO1987004435A3 (en) | Xanthine compounds | |
| FR2687145B1 (fr) | Nouveaux anhydrides d'acides, leur preparation et leur emplot et | |
| FI851456L (fi) | Foerfarande foer framstaellning av 1-cyklohexyl-3,4-dihydroisokinolinderivat. | |
| ES2018404A6 (es) | Procedimiento para preparar nuevas 2-metoxicarbonil sustituido-n, n'-di-(trimetoxibenzoil)-piperazinas. |